$IPGP

IPG PHOTONICS CORP (IPGP): Results of Operations and Financial Condition

IPG PHOTONICS CORP (IPGP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IPG PHOTONICS ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Improving Industrial Demand and Continued Focus on Strategic Initiatives Drive Results Managing Costs and Driving Gross Margin Improvement MARLBOROUGH, Mass. – August 4, 2026 - IPG Photonics Corporation (N

Original reporting
Published Aug 4, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 12:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$IPGP
Bullish
high confidence
Mentioned
$IPGP
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$IPGPBullishHigh
01

Why it matters

Traders can update models immediately using the disclosed Q2 GAAP and non-GAAP metrics, cash flow and capex, and the explicit Q3 revenue, adjusted gross margin, adjusted operating expenses, adjusted EPS, and adjusted EBITDA ranges. The company also highlights tariff/trade uncertainty as an incremental risk to the outlook.

02

Market read

A same-day earnings and guidance release with quantified ranges for Q3, plus margin and segment-level drivers, is directly tradable for near-term positioning.

03

What to watch

Advanced Solutions revenue declined 9% YoY due to micromachining and defense weakness; investors may re-rate the segment if semiconductor growth does not continue to offset declines.

Relevance 7/10Novelty 9/10Timing: pre-market today, guidance and Q2 results released Aug 4, 2026
alphai · Earnings readIPGP · second quarter 2026 · ended June 30, 2026

IPG Photonics Announces Second Quarter 2026 Financial Results

Mixed quarter

Revenue increased 11% year over year and adjusted EBITDA increased 54%, while GAAP net income decreased 21% and Advanced Solutions sales decreased 9%.

Revenue
$278.6 million
11% y/y
Industrial Solutions
$237,043
16% y/y
Gross margin · GAAP
40.4%
EPS · non-GAAP
$0.58
93% y/y
third quarter of 2026 outlook
$265 million to $295 million
GM adjusted gross margin between 37.5% and 40.5%

Key metrics

as reported
MetricValueq/qy/y
RevenueGAAP$278.6 million11%
Cost of salesGAAP$166,056
Gross profitGAAP$112,524
Gross marginGAAP40.4%
Adjusted gross marginnon-GAAP40.7%
Sales and marketing expenseGAAP$23,818
Research and development expenseGAAP$31,004
General and administrative expenseGAAP$36,545
Settlement of litigation mattersGAAP$(166)
Impairment chargesGAAP$17,574
Gain on foreign exchangeGAAP$(782)
Total operating expensesGAAP$107,993
Operating incomeGAAP$4.5 millionNM
Operating marginGAAP1.6%
Interest income, netGAAP$7,110
Other income, netGAAP$900
Total other incomeGAAP$8,010
Income before provision for income taxesGAAP$12,541
Provision for income taxesGAAP$7,299
Net incomeGAAP$5.2 million(21)%
Earnings per diluted shareGAAP$0.12(25)%
Earnings per basic shareGAAP$0.12
Adjusted EBITDAnon-GAAP$48.5 million54%
Adjusted earnings per diluted sharenon-GAAP$0.5893%
Weighted average common shares outstanding, basicGAAP42,470
Weighted average common shares outstanding, dilutedGAAP42,913

Segments

SegmentRevenueq/qy/y
Industrial SolutionsGrowth in welding, marking, cleaning and additive manufacturing applications.$237,04316%
Advanced SolutionsLower revenue in micromachining and defense applications, partially offset by increased sales in semiconductor applications.41,537(9)%

third quarter of 2026 outlook

  • Revenue$265 million to $295 million
  • Gross marginadjusted gross margin between 37.5% and 40.5%
  • Operating expensesadjusted operating expenses of $92 million to $95 million
  • NoteAdjusted earnings per diluted share in the range of $0.30 to $0.60
  • NoteAdjusted EBITDA in the range of $35 million to $51 million
  • NoteAssumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 162 and Chinese yuan 6.81, respectively.

What drove it

  • Changes in foreign exchange rates increased revenue by approximately 2%.
  • Industrial Solutions accounted for 85% of total revenue.
  • Emerging growth products accounted for 58% of total revenue, up from 53% in the prior quarter.
  • Sales increased 19% in Asia and 5% in Europe, while decreasing 2% in North America on a year-over-year basis.
  • GAAP gross margin and adjusted gross margin increased year over year, driven by lower product costs, lower inventory provisions, and $4.7 million in tariff refunds recorded in the period.
  • Book-to-bill remained above one in the second quarter.

Concerns

  • Advanced Solutions sales decreased 9% year over year.
  • GAAP net income decreased 21% year over year and GAAP earnings per diluted share decreased 25%.
  • The company recorded $17,574 of impairment charges.
  • The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook provided.
  • Guidance identifies trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions as factors that could affect actual results.

What to watch

  • Industrial Solutions demand across welding, marking, cleaning and additive manufacturing applications.
  • Advanced Solutions sales in semiconductor applications, micromachining and defense applications.
  • The progression of emerging growth products, which accounted for 58% of total revenue.
  • Adjusted gross-margin performance against the third-quarter range of 37.5% to 40.5%.
  • The impact of trade environment uncertainty and tariff policies on demand, costs and results.
  • The recently announced acquisition of Lumibird Medical and its strategic expansion into medical markets in Advanced Solutions.

Balance sheet and cash flow

  • Cash and cash equivalents of $399,225 as of June 30, 2026, compared with $403,790 as of December 31, 2025.
  • Short-term investments of 472,094 as of June 30, 2026, compared with 435,538 as of December 31, 2025.
  • Long-term investments of 32,693 as of June 30, 2026, compared with 76,533 as of December 31, 2025.
  • Total assets of $2,424,567 as of June 30, 2026, compared with $2,424,280 as of December 31, 2025.
  • IPG generated $37.8 million in cash flow from operations during the second quarter.
  • IPG spent $20.7 million on capital expenditures during the second quarter.

Analysis

IPG reported second-quarter revenue of $278.6 million, up 11% year over year, marking its third consecutive quarter of double-digit year-over-year revenue growth according to management. Industrial Solutions was the principal source of growth, with sales of $237,043, up 16%, supported by welding, marking, cleaning and additive manufacturing applications. Changes in foreign exchange rates increased revenue by approximately 2%.

The revenue mix was uneven. Industrial Solutions accounted for 85% of total revenue, while Advanced Solutions sales of 41,537 decreased 9% year over year. The Advanced Solutions decline reflected lower micromachining and defense revenue, partly offset by increased semiconductor-application sales. Emerging growth products accounted for 58% of total revenue, compared with 53% in the prior quarter. Regionally, sales increased 19% in Asia and 5% in Europe, while North America sales decreased 2% year over year.

Margins and adjusted earnings improved, but GAAP profitability remained constrained. GAAP gross margin increased to 40.4% from 37.3%, and adjusted gross margin increased to 40.7% from 37.8%, driven by lower product costs, lower inventory provisions and $4.7 million in tariff refunds. Adjusted EBITDA increased 54% to $48.5 million and adjusted earnings per diluted share increased 93% to $0.58. GAAP operating income was $4.5 million, while GAAP net income declined 21% to $5.2 million and diluted EPS declined 25% to $0.12. The period included $17,574 of impairment charges.

Cash flow from operations was $37.8 million, and capital expenditures were $20.7 million during the quarter. Cash and cash equivalents were $399,225 as of June 30, 2026, compared with $403,790 as of December 31, 2025. For the third quarter, IPG guided revenue to $265 million to $295 million, adjusted gross margin to 37.5% to 40.5%, adjusted operating expenses to $92 million to $95 million, adjusted EPS to $0.30 to $0.60 and adjusted EBITDA to $35 million to $51 million. Management said book-to-bill remained above one, but identified elevated uncertainty from trade conditions and tariff policies as a risk to the outlook.

Management, verbatim

We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted gross margin and adjusted EPS above our expectations.

Dr. Mark Gitin, Chief Executive Officer of IPG Photonics

Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team's focused execution of our growth strategy.

Dr. Mark Gitin, Chief Executive Officer of IPG Photonics

Not in the filing

stated, not guessed
  • Previous-period outlook was not provided; comparison of actual results with prior guidance is unavailable.
  • Free cash flow was not reported.
  • Share repurchases and dividends during the period were not reported.
  • Debt was not reported in the provided filing text.
  • Third-quarter tax-rate guidance was not reported.
  • Quarter-over-quarter revenue, segment revenue, margin, earnings and cash-flow comparisons were not reported for the applicable line items.
  • A GAAP operating-expense guidance figure was not reported.
  • The provided filing text is truncated after the balance-sheet total-liabilities line; complete liabilities and equity details are unavailable.

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting IPG Photonics second-quarter 2026 results and third-quarter 2026 guidance.

Company-level read

Ticker impact

$IPGPBullishHigh confidence
Context

IPG Photonics reported Q2 2026 revenue of $278.6M (+11% YoY) and guided Q3 revenue to $265M-$295M with adjusted EPS $0.30-$0.60.

Expected impact

Near-term bias higher if investors focus on double-digit revenue growth, adjusted gross margin improvement, and book-to-bill above 1.

Evidence & confidence

The release provides multiple decision-grade datapoints: GAAP and non-GAAP results, adjusted EBITDA and adjusted EPS, and explicit Q3 ranges, all tied to demand and margin drivers. The main offset is explicit tariff/trade uncertainty, but guidance is still provided with a defined range.

Market effects

Laser and photonics demand signals split between Industrial Solutions strength (welding, marking, cleaning, additive) and Advanced Solutions softness in micromachining/defense, with semiconductor growth offsetting.

Asia sales up 19% YoY and Europe up 5% YoY, while North America down 2% YoY, shaping regional demand expectations for photonics equipment buyers.

Tariff and trade-environment uncertainty is explicitly flagged as a risk to the outlook, which can influence sentiment across industrial automation and advanced manufacturing capex.

Counterpoint

Despite revenue growth, GAAP profitability weakened (net income down 21% YoY; operating income down to $4.5M from $0.1M), suggesting the quality of earnings may be more dependent on adjustments and tariff refunds.

Key entities

  • IPG Photonics Corporation

    NASDAQ-listed laser and photonics company reporting Q2 2026 results and issuing Q3 2026 guidance.

  • Lumibird Medical

    Recently announced acquisition referenced as accelerating expansion into medical markets within Advanced Solutions.

  • CROSSBOW directed energy system

    Company cites continued interest in its CROSSBOW system as part of demand commentary.

Every IPGP earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$IPGPMedAI 8/10

Why IPG Photonics Rallied Today

IPG Photonics (IPGP) shares rose 7.9% after the company reported mixed Q2 results and issued stronger-than-expected guidance. Revenue rose 11.1% to $278.6M, missing estimates, while adjusted EPS nearly doubled to $0.58. For Q3, IPG guided $280M revenue and $0.45 adjusted EPS at the midpoint.

$IPGPMed

IPG Photonics Q2 Earnings Call Highlights

IPG Photonics (IPGP) reported Q2 GAAP gross margin of 40.4% and adjusted gross margin of 40.7%, with GAAP diluted EPS of $0.12 and adjusted diluted EPS of $0.58. Management cited battery-manufacturing wins, additive manufacturing growth, and semiconductor momentum, plus CROSSBOW shipments for Lockheed Martin. IPG agreed to acquire Lumibird Medical, expected to close Q4 2026. Q3 revenue guidance is $265M to $295M.

$IPGPMedAI 8/10

IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG's Medical Laser Growth Platform

IPG Photonics (NASDAQ: IPGP) said it entered a binding offer to acquire Lumibird Medical. The deal is for €300 million cash-free, debt-free, plus an earnout up to €50 million tied to 2026-2027 metrics. IPG expects the transaction to be accretive to gross margin, EBITDA, and adjusted EPS, and to close in Q4 2026. Lumibird Medical reported €112.2m revenue and €24.1m EBITDA in 2025.